Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,236 | Dovepress* | 6,351+ | 683 | 7,034 | |
| PubMed Central* | 885 | 272 | 1,157 | ||
| Totals | 7,236 | 955 | 8,191 | ||
| *Since 3 May 2021 | |||||
View citations on PubMed Central and Google Scholar